← Back to Search

Behavioural Intervention

Speech Perception Assessment via Mobile App for Hearing Loss (VALDE-MU Trial)

N/A
Recruiting
Research Sponsored by Cochlear
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day - immediately post screening.
Awards & highlights

VALDE-MU Trial Summary

This trial will study how a mobile app can measure & validate hearing in adults who have cochlear implants.

Who is the study for?
This trial is for adults over 18 who use a hearing device, are fluent in the language of the speech perception test, and can consent to participate. It's not for Cochlear employees, those involved in other drug/device trials within 30 days, or pregnant women.Check my eligibility
What is being tested?
The study tests a Mobile Research App designed to measure speech perception in adult cochlear implant users. It's an international feasibility study comparing app results with standard-of-care methods.See study design
What are the potential side effects?
Since this trial involves a non-invasive mobile app for testing speech perception and does not include drugs or invasive procedures, there are no direct physical side effects associated with its use.

VALDE-MU Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day - immediately post screening.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day - immediately post screening. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To determine if test-retest reliability

VALDE-MU Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Delivery of speech perception materials using the experimental method (Mobile Research App)Experimental Treatment1 Intervention
Group II: Delivery of speech perception materials using the experimental method (MRA) in home environmentExperimental Treatment1 Intervention
Group III: Standard of Care validated delivery of speech perception materialsActive Control1 Intervention

Find a Location

Who is running the clinical trial?

CochlearLead Sponsor
90 Previous Clinical Trials
6,033 Total Patients Enrolled
81 Trials studying Hearing Loss
5,764 Patients Enrolled for Hearing Loss
~15 spots leftby Aug 2024